【24h】

Preface

机译:前言

获取原文
           

摘要

Peritoneal surface oncology is an emerging specialty in India. Cytoreductive surgery (CRS) and HIPEC have become popular worldwide for treating peritoneal metastases (PM) from various malignancies over the last couple of decades. This treatment can cure certain selected patients with PM and substantially prolong life and/or improve the quality of life in others. In India, most of the experience dates back to the last 5?years. The first workshop on peritoneal surface malignancies, in India, was held under the aegis of the Peritoneal Surface Oncology Group International (PSOGI) from the 16-18th of April,2015, at Fortis Hospital Bangalore, an initiative taken by Dr. Paul Sugarbaker. This 3?day program was attended by 70 surgical oncologists from all over the country in various stages of their careers. The program director Dr. Sugarbaker along with other experts in the field, Prof David Morris, Prof Olivier Glehen and Dr. Diane Goere delivered lectures on all aspects of CRS and HIPEC. The workshop also included a live surgery demonstration by Dr. Sugarbaker.
机译:腹膜表面肿瘤学是印度新兴的专科。在过去的几十年中,细胞还原手术(CRS)和HIPEC在全世界范围内广泛用于治疗各种恶性肿瘤的腹膜转移(PM)。这种治疗可以治愈某些患有PM的患者,并大大延长寿命和/或改善其他患者的生活质量。在印度,大多数经验可以追溯到最近5年。由Paul Sugarbaker博士发起的倡议,于2015年4月16日至18日在国际腹膜表面肿瘤学小组(PSOGI)的主持下,在印度举行了有关腹膜表面恶性肿瘤的首个研讨会。来自全国各地的70名外科肿瘤学家参加了为期3天的计划,他们的职业生涯各不相同。计划主任Sugarbaker博士以及该领域的其他专家,David Morris教授,Olivier Glehen教授和Diane Goere博士就CRS和HIPEC的各个方面进行了演讲。研讨会还包括Sugarbaker博士的现场手术演示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号